Cargando…

MSC - targets for atherosclerosis therapy

Detalles Bibliográficos
Autores principales:	Colmegna, Ines, Stochaj, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366979/ https://www.ncbi.nlm.nih.gov/pubmed/30591619 http://dx.doi.org/10.18632/aging.101735

Ejemplares similares

Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Kizilay Mancini, Ozge, et al.
Publicado: (2015)

Erratum to: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Mancini, Ozge Kizilay, et al.
Publicado: (2017)

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes
por: Altaner, Cestmir, et al.
Publicado: (2019)

Nucleolar Organization and Functions in Health and Disease
por: Stochaj, Ursula, et al.
Publicado: (2020)

CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells
por: Psaroudis, Rose Triantafillia, et al.
Publicado: (2022)

S-nitrosylation and MSC-mediated body composition
por: Cao, Yenong, et al.
Publicado: (2015)

Imaging of MSC transplantation in neuroscience
por: Filippi, Miriam, et al.
Publicado: (2017)

Heterogeneity of MSC: Origin, Molecular Identities, and Functionality
por: Liu, Xueqing, et al.
Publicado: (2019)

Alternative approaches to preserve MSC progenitor potency
por: Kim, Nayoun, et al.
Publicado: (2017)

Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration
por: Abdelrazik, Heba, et al.
Publicado: (2023)

MSC therapy in livestock models
por: Harness, Ellen M, et al.
Publicado: (2022)

A tribute to Professor Seyyed Behrouz Mousavi, D.D.S, MSc, Endodontist
por: Mortazavi, Vajihesadat
Publicado: (2011)

Translating MSC Therapy in the Age of Obesity
por: Boland, Lauren, et al.
Publicado: (2022)

Targeting Phosphorylcholine in Established Atherosclerosis?
por: Tsiantoulas, Dimitrios
Publicado: (2020)

Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
por: Kholodenko, Irina V., et al.
Publicado: (2023)

Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases
por: Chu, Siwei, et al.
Publicado: (2023)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
por: Kizilay Mancini, Özge, et al.
Publicado: (2017)

Recent Developed Strategies for Enhancing Chondrogenic Differentiation of MSC: Impact on MSC-Based Therapy for Cartilage Regeneration
por: Zha, Kangkang, et al.
Publicado: (2021)

Kinetics of MSC-based enzyme therapy for immunoregulation
por: Burr, Alexandra, et al.
Publicado: (2019)

MSC-Derived Extracellular Vesicles in Tumors and Therapy
por: Luo, Tianjiao, et al.
Publicado: (2021)

MSC-EV therapy for bone/cartilage diseases
por: Kodama, Joe, et al.
Publicado: (2022)

Improving Cardiovascular Outcomes: The Era of Personalized Therapy in Atherosclerosis
por: Kabłak-Ziembicka, Anna
Publicado: (2022)

Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation
por: Kodiha, Mohamed, et al.
Publicado: (2014)

Nuclear Transport: A Switch for the Oxidative Stress—Signaling Circuit?
por: Kodiha, Mohamed, et al.
Publicado: (2012)

Quantitative analysis of the interplay between hsc70 and its co-chaperone HspBP1
por: Mahboubi, Hicham, et al.
Publicado: (2015)

Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance
por: Chu, Siwei, et al.
Publicado: (2020)

Dissecting the Signaling Events That Impact Classical Nuclear Import and Target Nuclear Transport Factors
por: Kodiha, Mohamed, et al.
Publicado: (2009)

Off to the Organelles - Killing Cancer Cells with Targeted Gold Nanoparticles
por: Kodiha, Mohamed, et al.
Publicado: (2015)

Mentor, Scholar, Academic, and a Massage Therapist: an Interview with Amanda Baskwill, PhD(c), MSc, RMT
por: Kennedy, Ann Blair
Publicado: (2019)

Novel insights into MSC-EVs therapy for immune diseases
por: Lai, Peilong, et al.
Publicado: (2019)

Shattering barriers toward clinically meaningful MSC therapies
por: Levy, Oren, et al.
Publicado: (2020)

MSC-based therapy in female pelvic floor disorders
por: Sima, Yizhen, et al.
Publicado: (2020)

MSC Based Therapies—New Perspectives for the Injured Lung
por: Behnke, Judith, et al.
Publicado: (2020)

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies
por: Zumla, Alimuddin, et al.
Publicado: (2020)

Nanotechnology for Targeted Therapy of Atherosclerosis
por: Hossaini Nasr, Seyedmehdi, et al.
Publicado: (2021)

Atherosclerosis and Autoimmunity
por: Spinelli, Francesca Romana, et al.
Publicado: (2018)

Sortilin and atherosclerosis
por: Mortensen, Martin B., et al.
Publicado: (2015)

Inflammation and Atherosclerosis
por: Ley, Klaus
Publicado: (2021)

Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy
por: Lin, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3dvepleck8goi8qlog9h9piit